In this Letter, an administrative error led to the publication of an incorrect version of the Competing Financial Interests (CFI) statement. Although the published CFI statement did reference the authors’ affiliation with D-Gen, it did not contain all of the information provided by the authors about the interests of the company. The CFI statement for this paper as originally published was “J.C. is a Director and J.C. and J.D.F.W. are shareholders of D-Gen Limited, which supplies antibody ICSM35.” The updated CFI statement is “J.C. is a Director and J.C. and J.D.F.W. are shareholders of D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, decontamination and therapeutics. D-Gen supplied antibody ICSM35.”
Additional information
The online version of the original article can be found at 10.1038/nature15369
Rights and permissions
About this article
Cite this article
Jaunmuktane, Z., Mead, S., Ellis, M. et al. Erratum: Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy. Nature 526, 595 (2015). https://doi.org/10.1038/nature15704
Published:
Issue date:
DOI: https://doi.org/10.1038/nature15704
